Over 150 Total Lots Up For Auction at One Location - MO 06/05

Dr. David Wong

Professor recognized for contributions to PET and Theranostics
September 12, 2018
Molecular Imaging PET
Dr. David Wong
NEWMARKET, Australia, Sept. 5, 2018 /PRNewswire/ -- Dr. David Chee Wong is a distinguished biographee of Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are chosen from among a pool of the most prominent professionals and are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Drawing upon more than three decades of professional experience, Associate Professor David Wong is presently the director of the Advanced PET and Nuclear Medicine Centre at Uniting Care Medical Imaging in Brisbane, Australia. In this position, he was instrumental involvement in the performance of the first Ga68 PSMA PET CT diagnostic imaging in men with prostate cancer on 16 July 2014 in Brisbane, Australia. Most recently in August 2017, David was involved in the first Lutetium 177 PSMA therapy in men with metastatic prostate cancer in Queensland, Australia.

A respected voice in the field of PET and radiology, David is an associate professor with the Centre of Advanced Imaging with the University of Queensland. Since the inception of his career, he has contributed numerous articles to professional journals pertaining to his areas of expertise. He was most recently credited as the co-author of "Flurodeoxyglucose Positron Emission Tomography May Be Helpful in the Case of Ductal Variant Prostate Cancer When Prostate Specific Membrane Antigen Ligand Positron Emission Tomography Scan is Negative," which was published in the Journal of Medical Imaging and Radiation Oncology in 2017. His other recent publications include, "The Use of 68 Ga-PSMA PET CT in Men with Biochemical Recurrence After Definitive Treatment of Acinar Prostate Cancer" and "Initial multicentre experience of 68Gallium PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited" in British Journal of Urology International. He was involved in the successful Wesley Research Institute's attainment of The Australian Cancer (ACRF) Cancer Research Facility grant in 2009 and most recently in 2017, ARC ITTC (Australian Research Council Industrial Transformation Training Centre with the University Queensland's Centre of Advanced Imaging.
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats
His awards have included the Rouse Travelling Fellowship, ANZSNR Symposium Neuroradiologicum Award, Schering Anniversary Research Grant, Philips Medical Prize, Brian Smith Memorial Award, Siemens Medical Solutions Prize, GE Medical Systems Research Prize, Amersham Poster Prize ANZAPNM Registrar Award, Johnson and Johnson Medical Educational Bursary and Princess Alexandra Hospital Private Practice Research and Education Trust Fund Scholarship.

You Must Be Logged In To Post A Comment

advertisement

 

advertisement

Molecular Imaging Homepage

IBA launches cyclotron for industrial-scale astatine-211 production
Cyclone iKure was developed to address production infrastructure limitations
GE HealthCare submits MIM KineticID for FDA review to support dynamic PET imaging
Dynamic PET tracks tracer behavior in blood and tissue over a longer period
Unlocking the Power of Theranostics with VERITON-CT: A New Era in Precision Medicine
Engineered with advanced digital technology and a patient-centered design, VERITON-CT offers a quantum leap in performance, accuracy, and efficiency.
Niowave breaks ground on $75 million facility to expand Actinium-225 production
New site will serve as its second dedicated production facility in Lansing, Michigan
The annual SNMMI meeting is right around the corner
Q&A with Heather Jacene, incoming SNMMI president
New radiotracers reshape access to neuroendocrine tumor imaging
Rollout of Gallium-68 DOTATATE and DOTATOC coincided with increased travel distances for patients
PharmaLogic opens PET radiopharmaceutical facility in Atlanta
Part of company's $250 million investment in U.S. radiopharma infrastructure
Clarity expands manufacturing network with Nucleus agreement for Cu-64 PSMA agent
Intended to support distribution across the US international markets of investigational prostate cancer imaging agent
SHINE gets $263 million conditional loan from DoE for Wisconsin Mo-99 facility
Intends to use a combination of fusion and fission processes to manufacture the isotope domestically
Siemens Healthineers and Radiopharm ink supply deal for RAD101 PET agent ahead of Phase 3 trial
Designed to help detect suspected recurrent brain metastases from solid tumors